Supernus Pharmaceuticals Aktie

33,60 EUR -0,20 EUR -0,59 %
35,42 USD -0,35 USD -0,98 %
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.1,88 Mrd. EUR

KGV1.221,10Div. Rendite0,00%

WKNA1JX3U

ISINUS8684591089

SymbolSUPN


Supernus Pharmaceuticals Umsatz, Kennzahlen, Bilanz/GuV

Supernus Pharmaceuticals: Die Aktie (in USD)

2023202220212020201920182017
0,021,040,982,362,102,051,08
0,021,131,012,412,162,131,13
0,021,040,982,362,102,051,08
0,000,000,000,000,000,000,00
0,000,000,000,000,000,000,00

Supernus Pharmaceuticals: Unternehmenskennzahlen (in USD)

2023202220212020201920182017
10,9410,8210,679,697,307,565,67
1.221,1034,2329,6710,6411,2916,1936,90
1.221,1034,2329,6710,6411,2916,1936,90
0,000,000,000,000,000,000,00
65,4048,2344,5046,9449,7244,8960,87
34,6051,7755,5053,0650,2855,1139,13

Supernus Pharmaceuticals: GuV (in Mio. USD)

2023202220212020201920182017
607,52667,24579,77520,40392,75408,90302,24
-8,9515,0911,4132,50-3,9535,2940,57
438,88494,39472,13447,94376,10393,54287,02
-11,234,725,4019,10-4,4337,1141,38
13,4045,61101,20184,00148,57144,4499,54
-70,62-54,93-45,0023,852,8645,1183,60
2,7760,7473,17168,65147,49140,18100,62
-95,44-16,99-56,6114,355,2239,3299,76
1,3260,7153,42126,95113,06110,9957,28
-97,8313,64-57,9212,291,8693,76-37,20

Supernus Pharmaceuticals: Bilanz (in Mio. USD)

2023202220212020201920182017
4879511.018842602556172
3,604,9413,1911,368,417,550,95
922886816745595453267
3,988,629,5325,1031,4369,3739,49
1.4091.8371.8331.5871.1981.009439
-23,320,2215,5332,5118,66129,6841,95

Supernus Pharmaceuticals: sonstige Angaben (in USD)

2023202220212020201920182017
0,021,131,012,412,162,131,13
-97,8712,44-58,3011,851,0488,93-38,59
0,021,040,982,362,102,051,08
-97,736,02-58,4412,552,3989,97-38,64
0,000,000,000,000,000,000,00
-------
652612575563464448422
6,546,432,1321,343,576,1616,25
Die Daten werden von FactSet zur Verfügung gestellt.
FactSet vereinheitlicht die Rechnungslegungsstandards IFRS und US-GAAP, um Unternehmenszahlen branchen- und länderübergreifend vergleichbar zu machen.